SecBot SecBot
8-K ·Filed Jun 15, 2026

PDSB

PDS Biotechnology Corp
NEUTRAL
Impact 2/10
Horizonweeks Processed5mo ago SEC0001140361-26-025121
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

This is a routine scheduling notice with no trading implications. Monitor the upcoming proxy statement for any shareholder proposals or governance changes, but no immediate action is warranted.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.02
T+0 close · Jun 15, 2026 · via day close
Latest settled
−71.27%
T+60 · $0.2930
Vs SPY
−72.28%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 15 $1.02entry
  2. T+1 · 5mo ago −5.88%α −5.29% · $0.9600
  3. T+5 · 5mo ago −7.73%α −6.34% · $0.9412
  4. T+20 · 4mo ago −26.94%α −26.19% · $0.7452
  5. T+60 · 2mo ago −71.27%α −72.28% · $0.2930
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

PDS Biotechnology Corp filed an 8-K to announce that its 2026 Annual Meeting of Stockholders is scheduled for August 10, 2026, and set a June 25, 2026 deadline for stockholder proposals under Rule 14a-8. This is a routine administrative filing with no material financial or operational impact.

Key Facts

  • 2026 Annual Meeting scheduled for August 10, 2026.
  • Stockholder proposal deadline set for June 25, 2026 under Rule 14a-8.
  • Filing contains no financial data, guidance, or material corporate events.

Financial Impact

Not specified

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-025121
Document: 0001140361-26-025121-index-headers.html0001140361-26-025121
Document: 0001140361-26-025121-index.html0001140361-26-025121
Document: 0001140361-26-025121.txt0001140361-26-025121

Track record

28 reports on PDSB

Performance horizon

7 of 14 bullish or bearish reports moved the stock their way by T+20. Best: +71.95% at T+20 after the Jul 22, 2026 report. 11 of 14 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $0.8726 Now $0.9240 +5.89% settles Dec 14
  2. Nov 12, 20264d ago SC 13D/A Neutral 4/10 Entry $0.9800 Now $0.9240 −5.71% settles Dec 11
  3. Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.03 Now $0.9240 −10.29% settles Dec 9
  4. Oct 20, 202627d ago 3 Neutral 2/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
  5. Oct 20, 202627d ago 8-K Neutral 4/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
  6. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $0.9605 Now $0.9240 −3.80% settles Nov 17
  7. Oct 14, 20264w ago S-3 Bearish 7/10 Entry $1.30 to $0.9800 Now $0.9240 +28.92% ▲ +24.62% +22.71% vs SPY
  8. Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.05 to $1.41 Now $0.9240 −11.58% ▲ +34.93% +38.10% vs SPY
  9. Sep 22, 20267w ago 8-K Bullish 6/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
  10. Sep 22, 20267w ago Press Release Bullish 7/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026